FOXO3 and breast neoplasm: Notably, in vivo studies of FOXO3a inhibition in a breast tumor model revealed reduced tumor size as compared to controls, thus providing support for our contention that inhibition of genes involved in cellular invasion may also result in reduced tumor volume [42].